Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 4Genitourinary 4Gastrointestinal 4Dermatologic 3Breast 2Thoracic 1Classical hematology 1

Conditions

Breast Neoplasms 2Lymphatic Metastasis 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Optical Imaging × Breast × Clear all
NCT07146295 2026-01-12

INFINITE

St. Antonius Hospital

Phase NA Recruiting
1,760 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT00783757 2017-07-27

TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer

Massachusetts General Hospital

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡